<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The potential long-term benefits of <z:chebi fb="0" ids="50114">estrogen</z:chebi> replacement therapy (ERT) in the prevention of <z:hpo ids='HP_0000939'>osteoporosis</z:hpo> and <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> have been reasonably well established </plain></SENT>
<SENT sid="1" pm="."><plain>However, the favorable effects of ERT on cognitive function and prevention of senile <z:hpo ids='HP_0000726'>dementia</z:hpo> in old age now represents a revitalized area of clinical research </plain></SENT>
<SENT sid="2" pm="."><plain>A growing body of experimental evidence has recently provided the neurobiologic basis to support the hypothesis that gonadal hormones such as <z:chebi fb="0" ids="50114">estrogen</z:chebi> have psychologic effects on human brain function and behavior </plain></SENT>
<SENT sid="3" pm="."><plain>Studies in women who have undergone <z:e sem="disease" ids="C0740421" disease_type="Disease or Syndrome" abbrv="">surgical menopause</z:e> have demonstrated that the menopause is associated with subclinical cognitive and affective dysfunction, which is improved by ERT </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, a growing body of evidence suggests that <z:chebi fb="0" ids="50114">estrogen</z:chebi> may be an effective therapy for senile <z:hpo ids='HP_0000726'>dementia</z:hpo> in some elderly women </plain></SENT>
<SENT sid="5" pm="."><plain>Recent epidemiologic studies have indicated that long-term postmenopausal ERT may prevent late-life <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> in older women </plain></SENT>
<SENT sid="6" pm="."><plain>Several clinical trials employing oral <z:chebi fb="0" ids="50114">estrogen</z:chebi> therapy have also observed that some aged women with senile <z:hpo ids='HP_0000726'>dementia</z:hpo> have improved cognitive and affective function after <z:chebi fb="0" ids="50114">estrogen</z:chebi> therapy </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> loss resulting in <z:e sem="disease" ids="C0009241" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive disorders</z:e>, including menopausal <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> and senile <z:hpo ids='HP_0000726'>dementia</z:hpo> in late life, may act via several mechanisms </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> may be an important growth factor for <z:chebi fb="0" ids="50114">estrogen</z:chebi>-responsive neurons </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> therapy may also have substantial neurochemical effects, direct effects on the vasculature, and effects on the generation of free radicals, which may be toxic to neurons </plain></SENT>
<SENT sid="10" pm="."><plain>At this time, several important clinical questions need to be answered regarding the role of ERT in the cognitive and affective dysfunctions associated with menopause and senile <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="11" pm="?"><plain>Should <z:chebi fb="0" ids="50114">estrogen</z:chebi> be used for menopausal women whose sole complaint is cognitive or affective dysfunction </plain></SENT>
<SENT sid="12" pm="?"><plain>Does long-term ERT prevent <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> in late life if initiated at the time of menopause </plain></SENT>
<SENT sid="13" pm="?"><plain>Can ERT improve cognition and affective function in postmenopausal women with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and does <z:chebi fb="0" ids="50114">estrogen</z:chebi> therapy prevent the progression of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> in these patients </plain></SENT>
<SENT sid="14" pm="?"><plain>Finally, do the vascular effects of <z:chebi fb="0" ids="50114">estrogen</z:chebi> play a role in the treatment or prevention of both <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>